TheStreet downgraded shares of Integer (NYSE:ITGR) from a b rating to a c+ rating in a report issued on Thursday morning, TheStreetRatingsTable reports.
ITGR has been the topic of a number of other research reports. Sidoti lifted their price objective on Integer from $100.00 to $108.00 and gave the company a buy rating in a report on Friday, May 8th. Benchmark assumed coverage on Integer in a research note on Thursday, May 14th. They set a buy rating and a $105.00 price target on the stock. KeyCorp decreased their price target on Integer from $90.00 to $87.00 and set an overweight rating on the stock in a research note on Friday, May 8th. Finally, ValuEngine raised Integer from a sell rating to a hold rating in a research note on Friday, May 8th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Integer has an average rating of Buy and a consensus price target of $100.00.
Shares of ITGR opened at $65.77 on Thursday. Integer has a twelve month low of $46.01 and a twelve month high of $99.95. The stock’s 50 day moving average is $71.16 and its two-hundred day moving average is $76.18. The firm has a market capitalization of $2.16 billion, a PE ratio of 29.90 and a beta of 1.20. The company has a current ratio of 3.77, a quick ratio of 1.56 and a debt-to-equity ratio of 0.82.
Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, July 30th. The medical equipment provider reported $0.32 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.08). Integer had a net margin of 6.10% and a return on equity of 11.48%. The business had revenue of $240.12 million during the quarter, compared to analysts’ expectations of $235.70 million. On average, sell-side analysts predict that Integer will post 3.36 EPS for the current year.
Several institutional investors have recently modified their holdings of ITGR. Wellington Management Group LLP raised its position in shares of Integer by 212.6% during the 1st quarter. Wellington Management Group LLP now owns 1,515,459 shares of the medical equipment provider’s stock worth $95,261,000 after purchasing an additional 1,030,734 shares during the last quarter. Norges Bank acquired a new position in shares of Integer during the 4th quarter worth approximately $32,239,000. Franklin Resources Inc. raised its position in shares of Integer by 80.9% during the 4th quarter. Franklin Resources Inc. now owns 772,520 shares of the medical equipment provider’s stock worth $62,134,000 after purchasing an additional 345,434 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its position in shares of Integer by 77.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 503,173 shares of the medical equipment provider’s stock worth $31,629,000 after purchasing an additional 219,992 shares during the last quarter. Finally, RK Capital Management LLC acquired a new position in shares of Integer during the 1st quarter worth approximately $9,624,000. Hedge funds and other institutional investors own 98.11% of the company’s stock.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Further Reading: How is the discount rate different from the Federal Funds rate?
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.